A Retrospective Cross-sectional Study on Prevalence and Susceptibility Pattern of Bacterial Pathogens Causing Urinary Tract Infections at a Teaching Hospital in Tehran, Iran

Background: Urinary tract infection (UTI) is the most prevalent infection among the community and hospitalized patients. Objectives: This study aimed to investigate the current antimicrobial susceptibility patterns among UTI agents in Tehran, Iran. Methods: This retrospective study analyzed 9836 urine samples collected from hospitalized patients within 2019 - 2020. The antibiotic susceptibility for commonly-used antibiotics was tested according to Clinical and Laboratory Standards Institute guidelines. Results: Based on the findings, Escherichia coli was the most prevalent etiological agent of UTIs (72.3%), followed by Klebsiella spp. (13.4%), Pseudomonasaeruginosa (4.8%), Acinetobacter spp. (2.8%), and other species (6.7%). Of isolated microorganisms, 943 cases (97%) belonged to Gram-negative bacilli; however, 32 cases (3.05 %) were Gram-positive cocci. The susceptibility rates of E. coli to amikacin, nitrofurantoin, gentamicin, imipenem, and cefoperazone were 88.4%, 87.5%, 68.3%, 65.9%, and 62.6%, respectively. The sensitivity rates of Klebsiella spp. isolates for amikacin, nitrofurantoin, and imipenem were 87.6%, 71.5%, and 68.9%, respectively. Conclusions: The results of the present study characterized the misuse of antibiotics in Iran. Iranian surveillance studies will assist clinicians in choosing the most appropriate empirical treatment and preventing infections caused by resistant organisms.

[1]  J. Lepe,et al.  Prevalence and Risk Factors for Multidrug-Resistant Organisms Colonization in Long-Term Care Facilities Around the World: A Review , 2021, Antibiotics.

[2]  Deborah A. Flusberg,et al.  Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  B. Kot,et al.  Antibiotic Resistance of Uropathogens Isolated from Patients Hospitalized in District Hospital in Central Poland in 2020 , 2021, Antibiotics.

[4]  R. Kelishadi,et al.  Antimicrobial Resistance in Hospitalized Patients with Community Acquired Urinary Tract Infection in Isfahan, Iran. , 2021, Archives of Iranian medicine.

[5]  I. Kyriakidis,et al.  Acinetobacter baumannii Antibiotic Resistance Mechanisms , 2021, Pathogens.

[6]  K. Palmer,et al.  The Clinical Efficacy of Nitrofurantoin for Treating Uncomplicated Urinary Tract Infection in Adults: A Systematic Review of Randomized Control Trials , 2021, Urologia Internationalis.

[7]  F. van Leth,et al.  Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review , 2021, JAC-antimicrobial resistance.

[8]  S. Khoshnood,et al.  Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran , 2020, New microbes and new infections.

[9]  M. Ali,et al.  Bacterial associated urinary tract infection, risk factors, and drug susceptibility profile among adult people living with HIV at Haswassa University Comprehensive Specialized Hospital, Hawassa, Southern Esthiopia , 2020, Scientific Reports.

[10]  Fenfen Li,et al.  Assessment of multidrug resistance in bacterial isolates from urinary tract-infected patients , 2020 .

[11]  B. Kot Antibiotic Resistance Among Uropathogenic Escherichia coli , 2019, Polish journal of microbiology.

[12]  K. Burián,et al.  Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot , 2019, Antibiotics.

[13]  M. Bahadoram,et al.  Antibiotic resistance patterns of urinary tract infections in the West of Iran , 2019, Journal of Nephropharmacology.

[14]  M. De Donato,et al.  Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela. , 2019, Biomedica : revista del Instituto Nacional de Salud.

[15]  J. Byron Urinary Tract Infection. , 2019, The Veterinary clinics of North America. Small animal practice.

[16]  A. Peleg,et al.  Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems. , 2019, Australian prescriber.

[17]  M. Medina,et al.  An introduction to the epidemiology and burden of urinary tract infections , 2019, Therapeutic advances in urology.

[18]  J. Navarro-Marí,et al.  Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives , 2018, Journal of medical microbiology.

[19]  شهره زارع کاریزی,et al.  بررسی الگوی مقاومت آنتیبیوتیکی جدایههای استافیلوکوکوس ارئوس مقاوم به متیسیلین بیمارستانهای اهواز , 2018 .

[20]  W. Hayajneh,et al.  Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study , 2018, Infection.

[21]  K. R. Keikhaie,et al.  Antibiotic Resistance in Acinetobacter baumannii Isolated from Patients with Urinary Tract Infections in Zabol, Iran , 2018 .

[22]  S. Essack,et al.  Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana , 2018, Antimicrobial Resistance & Infection Control.

[23]  Shirin Saberianpour,et al.  An Epidemiological Study on the Prevalence and Antibiotic Resistance Patterns of Bacteria Isolated from Urinary Tract Infections in Central Iran , 2017 .

[24]  B. Dormanesh,et al.  Methicillin-Resistant Staphylococcus aureus Isolated From Various Types of Hospital Infections in Pediatrics: Panton-Valentine Leukocidin, Staphylococcal Chromosomal Cassette mec SCCmec Phenotypes and Antibiotic Resistance Properties , 2015, Jundishapur journal of microbiology.

[25]  D. Paterson,et al.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology , 2015, Nature Reviews Urology.

[26]  Z. Fatima,et al.  Multidrug Resistance: An Emerging Crisis , 2014, Interdisciplinary perspectives on infectious diseases.

[27]  A. Bahador,et al.  Virulence Factors of Staphylococcus aureus Isolates in an Iranian Referral Children's Hospital , 2014, Osong public health and research perspectives.

[28]  S. Hultgren,et al.  Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics , 2012, Virulence.

[29]  G. E. Djavid,et al.  Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran. , 2010, Journal of infection in developing countries.